PosterSessionOnline

EUROPEAN CYSTIC FIBROSIS SOCIETY

44th European Cystic Fibrosis Conference

9-12 June 2021 Digital Conference

N. Poster

Poster title

Applicant name

Status


EPS2-001	Drug-induced liver injury from antibiotics administered to adult cystic fibrosis patients: is it a problem? A single-centre retrospective study	Rachael Meredith	Received

EPS3-001	Is variation in Pseudomonas aeruginosa (Pa) surface-enhanced Raman spectroscopy (SERS) spectra related to phenotype?	Danielle Allen	Received

EPS1-001	Physiotherapy practice of French cystic fibrosis children changed during lockdown due to COVID-19 pandemic	Marie Mittaine	Received

P-001	TCR repertoire in monozygotic cystic fibrosis twins	Burkhard Tmmler	Received

P-002	Genetic characteristics of the cystic fibrosis Polish patients registered in the public Matio Polish Cystic Fibrosis Foundation	Karolina Surma	Received

EPS3-002	Using rapid evaporative ionisation mass spectrometry (REIMS) for biomarker discovery and mechanistic studies of Pseudomonas aeruginosa stress responses	Rob Bradley	Received

EPS1-002	The impact of COVID-19 on the prescribing practice of specialist cystic fibrosis physiotherapist non-medical prescribers in the UK	Catherine Brown	Received

EPS3-003	Using airway organoids and Air Liquid Interface cultures to profile the spatial and temporal dynamics of Pseudomonas aeruginosa infections	Signe Lolle	Received

EPS1-003	Recommended shielding against COVID-19 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis	Elpis Hatziagorou	Received

EPS2-003	Lumacaftor-ivacaftor therapy and its impact on glucose tolerance in children with cystic fibrosis	Kathy McGrath	Received

EPS3-004	Depolarisation of the Pseudomonas aeruginosacytoplasmic membrane by Glatiramer acetate potentiates the antibacterial activity of tobramycin	Ronan Murphy	Received

EPS1-004	Audit of virtual exercise class during COVID-19 in children with cystic fibrosis	Zoe Johnstone	Received

EPS2-004	The role of Flash Glucose Monitoring System at annual review during the COVID-19 restrictions, within Cystic Fibrosis Diabetes Service at Blackpool Adult Cystic Fibrosis Centre. UK	Julie Knowles	Received

EPS2-005	Arm circumference and skinfolds vs. body mass index: a single-centre experience over two decades	Dorothea Appelt	Received

EPS1-005	Evaluating impacts of the change from clinic to home spirometry on clinicians and adults with cystic fibrosis	Tracey Daniels	Received

P-005	Mild variants of the CFTR gene in Russian patients without clinical manifestations	Yuliya Melyanovskaya	Received

P-006	The complex allele c.1399CT;1521_1523delCTT (L467F;F508del) of the CFTR gene in Russian cystic fibrosis patients	Nataliya Kashirskaya	Received

EPS3-006	Low induction of Antibiotic resistance by two new drugs against Pseudomonas aeruginosa in a clinical cohort of cystic fibrosis patients	Mette Kolpen	Received

EPS2-006	What do people with cystic fibrosis eat? Diet quality, macronutrient and micronutrient intakes compared to recommended guidelines in adults with cystic fibrosis: a systematic literature review	Nicola Drummond	Received

EPS1-006	A retrospective audit of home-based spirometry quality in a large UK adult cystic fibrosis centre	Ian Waller	Received

P-007	A novel cystic fibrosis-causing mutation identified in a newborn of African origin	Natalia Cirilli	Received

EPS1-007	Impact of COVID-19 on cystic fibrosis physiotherapy outpatient clinics	Emily Scott	Received

EPS2-007	How did the COVID-19 lockdown influence the nutritional status and body composition of cystic fibrosis patients in Poland?	Monika Mielus	Received

EPS3-007	Predictors of eradication failure at first isolation of MRSA in children with cystic fibrosis	Almala Pinar Ergenekon	Received

EPS2-008	The model for determining risk groups for the development of vitamin D deficiency and prevention algorithm in children with cystic fibrosis using the multifactor dimensionality reduction method	Elena Zhekaite	Received

P-008	Identification of two novel mutations (c.3639dup and ex16-17a dup) in the CFTR gene in Polish patient with cystic fibrosis	Sebastian Wardak	Received

EPS3-008	Evaluation of a fixed-step eradication regime in children with cystic fibrosis and detection of Pseudomonas aeruginosa	Simon Florian Grewendorf	Received

EPS1-008	Exercising online a Beaming good initiative	Gemma McCrea	Received

EPS3-009	Biofilm formation in methicillin-resistant Staphylococcus aureus isolated in cystic fibrosis patients is strain-dependent and differentially influenced by antibiotics	Agathe Boudet	Received

P-009	The investigation of the effect of electrolyte disorder on sweat test in newborns with positive cystic fibrosis screening test	Sevgi Pekcan	Received

EPS2-009	F508del genotype is an independent risk factor for reduced bone mineral density in children with cystic fibrosis	JASNA RODMAN BERLOT	Received

EPS1-009	Adapting services during the COVID-19 pandemic a patient evaluation of physiotherapy telephone reviews within multidisciplinary team virtual clinics	Sarah Fitzgerald	Received

P-010	Newborn screening for cystic fibrosis improves nutritional outcome: monocentric data of the first 4 years in Germany	Katharina Schtz	Received

EPS2-010	Pregnancy and cystic fibrosis: patients experience from pre-conception to birth	Marilyn Hagan	Received

EPS3-010	Clinical pharmacokinetics and dose recommendations for posaconazole gastro-resistant tablets in children with cystic fibrosis	Sian Bentley	Received

P-011	Cystic fibrosis - newborn screening (CF-NBS) start-up in Flanders (Belgium): report of first evaluation after two years	Marijke Proesmans	Received

P-012	Two years neonatal screening for cystic fibrosis in Republic of North Macedonia	Stojka Fustik	Received

P-013	Evaluation of improvements of the cystic fibrosis newborn screening protocol in the Netherlands	Marelle Bouva	Received

P-015	Evaluation of the specificity and sensitivity of the cut-off values of immunoreactive trypsinogen in the cystic fibrosis newborn screening program	Tugba Ramasli Gursoy	Received

P-016	The role of clinical and laboratory findings in the diagnosis of cystic fibrosisin children with positive newborn screening	Tugba Ramasli Gursoy	Received

P-017	Different ethnical distribution of the incidence of cystic fibrosis in Republic of North Macedonia	Violeta Anastasovska	Received

P-018	Follow-up of children with Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID) in Switzerland	Orell Imahorn	Received

P-019	Inconclusive Cystic Fibrosis Positive Neonatal Screening (CFSPID): clinical outcomes	Silvia Gartner	Received

P-020	CFTR mutation panel in detecting cystic fibrosis screen positive inconclusive diagnosis patients (CFSPIDs) in the Marche Region, Italy	Natalia Cirilli	Received

P-021	An evaluation of the cystic fibrosis newborn screening service at Royal Manchester Childrens Hospital - experience from a tertiary service provider in Northwest United Kingdom	Anirban Maitra	Received

P-022	Evaluation of hearing and vestibular system in patients with cystic fibrosis	Beste zsezen	Received

P-023	Characterisation of CFTR function in a patient with the F508del/CFTRdup1-3 genotype	Senne Cuyx	Received

P-024	Pili annulati: is it a new finding in cystic fibrosis?	SEVG&304; PEKCAN	Received

P-025	Systems biology modelling of CFTR maturation to predict possible active compound combinations	Liza Vinhoven	Received

P-026	Characterisation of F508del-CFTR rescue by corrector MCG1516A	Mafalda Bacalhau	Received

P-027	Identification of corrector combinations to increase the rescue of F508del-CFTR traffic and function	Filipa Castela Ferreira	Received

P-028	Identification of novel F508del-CFTR correctors among triazole derivative compounds	Mafalda Bacalhau	Received

P-029	First report: Kaftriovs. Symkeviin intestinal organoids	Eva Furstova	Received

P-030	Metabolomic impact of the restoration of CFTR activity in the respiratory epithelium	Emmanuelle Bardin	Received

P-031	The last 10: small molecule screening for correctors of rare CFTR processing mutations	Marjolein Ensinck	Received

P-032	Chemical optimisation of a PI3Ky competing peptide for the therapy of cystic fibrosis	Angela Della Sala	Received

P-033	Therapeutic approach by translational suppression of non-sens mutation in CFTR gene	Sabrina Karri	Received

P-034	Novel insights into the therapeutic potential of antisense oligonucleotides as splicing modulators in respiratory and intestinal patient-derived model systems	Noemie Stanleigh	Received

P-035	iPSC-derived macrophages from cystic fibrosis patients as a cell source to establish in vitro infection models and a drug screening platform	Claudio Rodríguez-González	Received

P-036	Analysis of the dysfunction of cystic fibrosis macrophages	Claudio Rodríguez-González	Received

P-037	Elexacaftor/tezacaftor/ivacaftor improve lung disease in patients with advanced cystic fibrosis homozygous for the F508del mutation	Donatello Salvatore	Received

P-038	An Italian centre experience with elexacaftor-tezacaftor-ivacaftor therapy in cystic fibrosis patients with advanced lung disease	Chiara Rosazza	Received

P-039	The clinical impact of triple CFTR modulator therapy in a cohort of people with CF and severe lung disease	Orla Fanthorpe	Received

P-040	Compassionate use triple therapy CFTR modulation (Kaftrio) in severe disease. Single-centre, real-world clinical outcomes, safety and tolerability	David Morrissy	Received

P-041	Effect of thetriplecombination of CFTR correctors and potentiatoron lung function, BMI and the Brasfield score in adolescents with cystic fibrosis	Marina Praprotnik	Received

P-042	RECOVER - the Real World Clinical Outcomes with Novel Modulator therapy combinations in people with cystic fibrosis	Paul McNally	Received

P-043	A snapshot of respiratory microbiology results pre- and post-commencing Kaftrio	Laura Jenkins	Received

P-045	Are people with cystic fibrosis reducing their medication since Kaftrio initiation?	Michael Dooney	Received

P-046	Menstrual abnormalities linked to Kaftrio	Michael Dooney	Received

P-047	Impact of tezacaftor/ivacaftor/elexacaftor on outcome in a patient with I336Kmutation and a minimal function mutation R553X	Sivagurunathan Sutharsan	Received

P-048	Olfactory dysfunction: impact of highly effective modulator therapy	Daniel Beswick	Received

P-049	Tolerance induction (hyposensitisation) in drug intolerance to CFTR modulators	Patience Eschenhagen	Received

P-050	Drug desensitisation for lumacaftor/ivacaftor - step-by-step to drug tolerance	Julia Westhoff	Received

P-051	Rollout of Kaftrio to adult cystic fibrosis patients at the Royal Brompton Hospital during a global pandemic	Elaine Bowman	Received

P-052	Managing the roll out of the cystic fibrosis modulator therapy Kaftrio at a large UK adult centre	Constance (Connie) Takawira	Received

P-053	Real-life clinical effects of therapy with lumacaftor and ivacaftor in patients with cystic fibrosis	Isabella Comello	Received

P-054	Clinical outcomes in people with cystic fibrosis treated with lumacaftor/ivacaftor in routine clinical practice in Sweden	Anders Lindblad	Received

P-056	Intestinal current measurement (ICM) in cystic fibrosis paediatric patients - a pilot study	Magdalena Postek	Received

P-057	Cystic fibrosis children not eligible for modulators therapy - data from a tertiary paediatric centre in Northwest United Kingdom	Ghulam Mujtaba	Received

P-058	The effect of hypertonic saline treatment in preschoolers with cystic fibrosis on lung structure as measured by chest computed tomography (CT). SHIP-CT study: feasibility of CT scan protocol	Harm A.W.M. Tiddens	Received

P-059	A double-blind randomised multicentre European study of linoleic acid supplementation for one year in patients with cystic fibrosis	Birgitta Strandvik	Received

P-060	Phage therapy for chronic Pseudomonas aeruginosa infections in cystic fibrosis patients	Maya Kahan-Hanum	Received

P-061	The UK Clinical Trials Accelerator Platform - a national cystic fibrosis clinical trials network increasing access to clinical trials for the UK cystic fibrosis community	Rebecca Brendell	Received

P-062	Impact of the SARS-CoV-2 pandemic on clinical trials in the ECFS-CTN during 2020	Fiona Dunlevy	Received

P-063	Community involvement in shaping cystic fibrosis clinical trials	Lorna Allen	Received

P-064	How does early weight gain explain the effect of childhood socioeconomic conditions on lung function for children with cystic fibrosis? A UK Registry-based study	Daniela Schlter	Received

P-066	Lung function and pulmonary exacerbations among individuals with cystic fibrosis living near composting facilities in the United Kingdom	Muhammad Saleem Khan	Received

P-067	Mechanisms for the effect of CFRD on mortality: a causal mediation analysis using UK cystic fibrosis Registry data	Kamaryn Tanner	Received

P-068	Estimating the long-term effects of insulin on outcomes in cystic fibrosis-related diabetes: a target trial approach	Emily Granger	Received

P-069	Cystic fibrosis-related liver disease a decade of experience	Ana Mocic Pavic	Received

P-070	Epidemiology of nontuberculous mycobacteria in a single adult cystic fibrosis centre	Ayesha Kumar	Received

P-071	Real-world pregnancy data and outcomes in an era post-CFTR modulation therapies: an Irish centres perspective	Anina Ratjen	Received

P-072	Psychometric validation of the Cystic Fibrosis Impact Questionnaire: a patient-reported outcome instrument assessing the life impacts of cystic fibrosis	Daniel Serrano	Received

P-073	Influence of assessment tool and publication type on the reported prevalence of depression and anxiety in adults with cystic fibrosis: a meta-analysis	Louise Lord	Received

P-074	Setting up a framework for the collection of patient-reported outcomes in the real world: trials and tribulations	Elise Lammertyn	Received

P-075	Are there lessons to be learned from cystic fibrosis patient deaths and the timing of lung transplant referral?	Kavita Dave	Received

P-076	Using the Cystic Fibrosis Foundation consensus guidelines to assess the timing of lung transplant referral for individuals with cystic fibrosis in a single large adult UK centre: do they help?	Kavita Dave	Received

P-077	Clinical factors affecting timing of referral for lung transplantation for people with cystic fibrosis: a national comparison of opinions between adult cystic fibrosis and transplant centres	Kavita Dave	Received

P-078	The burden of cystic fibrosis beyond medical costs in Switzerland	Christina Tzogiou	Received

P-079	Using a learning health system to understand medicine waste in cystic fibrosis the Easy Medicines for Burden Reduction And Care Enhancement (EMBRACE) study	Amanda Bevan	Received

P-081	30 years of organisation of care for cystic fibrosis patients in the Russian Federation	Yuliya Melyanovskaya	Received

P-082	The National Cystic Fibrosis Patient Registry of the Russian Federation 9 years of experience (2011-2019)	Nataliya Kashirskaya	Received

P-083	Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study	Elliot McClenaghan	Received

P-084	The impact of the SARS-CoV-2 pandemic on people living with cystic fibrosis in Ireland: real-world data from the Irish cystic fibrosis registry	Huw Rees	Received

P-085	Impact of COVID-19 on hospital services and specialist care of adults with cystic fibrosis	Rini Bhatnagar	Received

P-086	The impact of COVID-19 in people with cystic fibrosis a single-centre experience	Georgina Aldous	Received

P-087	Impact of COVID-19 on mental health of children with cystic fibrosis and their parents	Rini Bhatnagar	Received

P-088	Impact of COVID-19 and cocooning on employment of people with cystic fibrosis	Rini Bhatnagar	Received

P-089	Coronavirus infection (COVID 19) in children with cystic fibrosis of the Russian Federation	Yuliya Melyanovskaya	Received

P-090	A UK survey on changes in managing people with cystic fibrosis during the COVID-19 pandemic	Saffana Hameed	Received

P-091	Regularity of check-ups at the cystic fibrosis centre in the time of COVID-19 pandemic	Ivana Todori&263;	Received

P-092	Embedding an electronic patient record into a developing UK service and impact during the COVID-19 pandemic - Blackpool Adult Cystic Fibrosis Service (BACFS)	Natasha Pickering	Received

P-094	Facilitating cystic fibrosis research during the COVID-19 pandemic	Sharon Burnett	Received

P-095	Effect of age and genotype on lung function in children with cystic fibrosis	Shadrina Vera	Received

P-096	Long-term follow-up of adolescent and adult patients with cystic fibrosis: a single centres experience	Asl&305; &304;mran Y&305;lmaz	Received

P-097	Whos talking about cystic fibrosis? The changing landscape of internet postings related to cystic fibrosis: a two-year comparative study	Tamara Vagg	Received

P-098	Change in FEV1 after standardised care algorithm for cystic fibrosis patients: quality improvement project	Muruvvet Cenk	Received

P-100	Quality of home spirometry performance amongst adults with cystic fibrosis	Jody Bell	Received

P-101	Provision of home spirometry in a physiologist-led service: experiences from a large adult cystic fibrosis centre	Scott Hawkes	Received

P-102	Utility of Dynamic Chest Radiography (DCR) for calculating lung volume subdivisions in adult people with cystic fibrosis	Thomas Simon FitzMaurice	Received

P-103	Longitudinal SF6 multiple breath washout testing in children aged 0-4 years with cystic fibrosis	Rikke Sandvik	Received

P-104	Multiple-breath nitrogen washout test and structural lung damage in adult patients with cystic fibrosis	Alexander Cherniak	Received

P-105	Lung clearance index in monitoring response to antibiotic therapy in children with cystic fibrosis	Katarzyna Walicka-Serzysko	Received

P-106	Positioning may not affect lung clearance index	TJ BAKER	Received

P-107	Lung clearance index in Bulgarian patients with cystic fibrosis	Boryana Gospodinova	Received

P-108	Cross-sectional and longitudinal comparison of N2 and SF6 multiple breath washout in children with cystic fibrosis aged 2-45 months	Rikke Sandvik	Received

P-109	Regional assessment of lung function using non-contrast MRI in people with cystic fibrosis	Jonathan Brooke	Received

P-110	A soft, flexible, wearable device for cough detection in paediatric cystic fibrosis patients	Andreas Tzavelis	Received

P-111	CT-signs and the effectiveness of surgical treatment of sinonasal disease in children with cystic fibrosis	Yulia Gorinova	Received

P-112	Sleep disorders and exercise capacity in adult patients with cystic fibrosis in the Republic of North Macedonia	Tatjana Jakovska Maretti	Received

P-113	Integration of Qi Gong sessions into a respiratory rehabilitation program: the experience of the CF Centre in Roscoff (France)	Laetitia Gueganton	Received

P-114	Neutrophil effector responses to cystic fibrosis clinical isolates of Pseudomonas aeruginosa	Kayla Fantone	Received

P-115	Effectiveness of different eradication treatment protocols for the first Pseudomonas aeruginosa isolation in paediatric cystic fibrosis patients	Birce Sunman	Received

P-116	Clinical characteristics of frequent and infrequent pulmonary exacerbations of cystic fibrosis lung disease	Claire Houston	Received

P-118	Lung ultrasound in cystic fibrosis exacerbations	Ioana Ciuca	Received

P-119	Improving Home IV outcomes	Christina Ryan	Received

P-120	Bridging the gap enhancing a multidisciplinary team Home IV service to reduce discrepancy in cystic fibrosis care	Victoria Kendall	Received

P-121	The effect of training about nebuliser cleaning and disinfection on the knowledge levels and practises of the caregivers of patients with cystic fibrosis	Muruvvet Cenk	Received

P-122	The role of the clinical pharmacy specialist in monitoring adherence to inhaled therapies in patients with cystic fibrosis in the Republic of North Macedonia	Marija Atanasova Nadzinska	Received

P-123	Adaptive immune response to Mycobacterium abscessus complex and cross-reactivity of BCG vaccination	Renan Mauch	Received

P-124	Implementing an anti-emetic protocol improves morbidity associated with intravenous therapy for Mycobacterium abscessus in children	Anupama Menon	Received

P-125	Impact of infection withAchromobacterspp.on clinical outcome in paediatric patients with cystic fibrosis	Birce Sunman	Received

P-127	Pulsed intravenous methylprednisolone for allergic bronchopulmonary aspergillosis in cystic fibrosis	Tamsin Thornton	Received

P-128	A review of inhaled corticosteroid prescribing in an adult cystic fibrosis population	Claire McKeown	Received

P-129	Induced sputum as a minimally invasive sample to investigate airway inflammation in the early course of cystic fibrosis	Vincent Giacalone	Received

P-130	Chronic inflammation biomarkers and lung function in cystic fibrosis patients	Mihaela Dediu	Received

P-132	The Induced Immune response in CF patients	Mads Lausen	Received

P-133	Impact of specialised pro-resolving lipid mediators on cystic fibrosis airway epithelial cell functions	Malle Briottet	Received

P-134	SARS-CoV-2 infection in cystic fibrosis during the first pandemic wave in Italy: a multicentre prospective study with a control group	Carla Colombo	Received

P-136	Relationship between cystic fibrosis disease severity and susceptibility to COVID-19 infection	MERVE ATALAY	Received

P-137	COVID-19 in cystic fibrosis patients with and without lung transplantation: the Zurich cohort	Carolin Steinack	Received

P-139	Evaluating the impact of a telemedicine service during the COVID-19 pandemic in people with cystic fibrosis	Alex Bull	Received

P-140	TeCC (TeleMedicine, Cystic Fibrosis, Corona-Virus) study in a previous telemedicine-naive centre: clinical challenges, outcomes, and user experience in the first six months of a global pandemic	David Morrissy	Received

P-142	Lung and gut microbiota signatures in cystic fibrosis mice challenged with Pseudomonas aeruginosa	Annamaria Bevivino	Received

P-145	Unwanted effects of an essential oil component, citral, on the susceptibility of Pseudomonas aeruginosato antibiotics	Alexandre Tetard	Received

P-146	Intra-patient evolution of a pulmonary strain of Pseudomonas aeruginosa,from primocolonisation until after lung transplant	Susie Gaillot	Received

P-148	Different treatment regimens in first isolation of Pseudomonas aeruginosa	Cansu Yilmaz Yegit	Received

P-149	Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosaclinical isolates from people with cystic fibrosis	Callum Sloan	Received

P-150	Competitive fitness experiments of CF isolates of Pseudomonas aeruginosa in human and murine precision-cut lung slices (PCLS)	Lion Wege	Received

P-151	Improved isolation yields for bacteriophage active against Staphylococcus aureus	Joshua Iszatt	Received

P-152	Clinical findings and long-term effect of methicillin-resistant Staphylococcus aureus isolation in patients with cystic fibrosis	Beste Ozsezen	Received

P-153	Exophiala dermatitidis infection in cystic fibrosis patients accelerates lung function decline: a retrospective single-centre review of historical lung function	Gemma Ford	Received

P-154	Exophiala dermatitidis can undergo patient-patient transmission in cystic fibrosis patients	Jonathan Ayling-Smith	Received

P-155	Identification of an evolutionary split in Burkholderia multivorans using phylogenomics: does it have any impacts on the ability to cause cystic fibrosis lung infection?	Kasia Parfitt	Received

P-156	Mycobacterium abscessus treatment in adult patients with cystic fibrosis: case series and review	Amel Alameeri	Received

P-157	Monitoring the distribution and genotypic diversity of Burkholderiales bacteria in Russian cystic fibrosis patients in the year of the COVID-19 pandemic	Olga Voronina	Received

P-158	Fungal airway colonisation in cystic fibrosis patients in the Institute for Respiratory Diseases in Children - Skopje, Republic of North Macedonia	Ivana Arnaudova Danevska	Received

P-159	Relationship between clinical and environmental strains of emerging opportunistic pathogens in cystic fibrosis and diversity in the home environment	Quentin Menetrey	Received

P-160	Detection and management of non-tuberculous mycobacteria in cystic fibrosis patients in a tertiary paediatric centre	Harriet Wayman	Received

P-162	Pneumococcal and influenza vaccination coverage level: data from a cystic fibrosis centre	Elpis Hatziagorou	Received

P-163	Effects of the SARS-CoV-2 pandemic on attendance at the cystic fibrosis centre and the definition of the microbiological status of cystic fibrosis patients in Tuscany	Daniela Dolce	Received

P-164	What is the tolerance of antibiotic dry powder inhalers in patients with cystic fibrosis?	Paul Wilson	Received

P-165	Improvement in antibiotic usage and ppFEV1 with compassionate use of elexacaftor, tezacaftor and ivacaftor (ETI) for patients with cystic fibrosis	Olivia Baker	Received

P-166	Prevalence of cystic fibrosis-associated liver disease in Albanian cystic fibrosis patients	Irena Kasmi	Received

P-167	Prevalence of liver disease in cystic fibrosis patients in the Institute for Respiratory Diseases in Children - Skopje, Republic of North Macedonia	Ivana Arnaudova Danevska	Received

P-168	Use of faecal elastase in patients with cystic fibrosis and mutation analysis in the Republic of North Macedonia	Tatjana Jakovska Maretti	Received

P-169	Trends in Glycaemic Control in a Cohort of Patients with Cystic Fibrosis Related Diabetes	Rahana Khanam	Received

P-170	Current status of cystic fibrosis-related diabetes in the Bulgarian cystic fibrosis population	GUERGANA PETROVA	Received

P-171	Adult cystic fibrosis diabetes patient education and care needs: have your say - a patient survey	Katrin Kosbab-Jackson	Received

P-172	Patient experience of Manchester Virtual Cystic Fibrosis-Related Diabetes Clinic during the COVID-19 pandemic	Amanda Brennan	Received

P-173	Investigation of cyproheptadine as an appetite stimulator in 6 children with cystic fibrosis with a suboptimal nutritional status	Sara Van Meerbeeck	Received

P-174	The association between body composition and respiratory outcomes for patients with cystic fibrosis	Lidia Sheibani	Received

P-175	Nutritional status, lung function and adequacy of micronutrient supplementation in children with cystic fibrosis	Tena Niseteo	Received

P-176	The benefits of changing to a cystic fibrosis-specific combined fat-soluble vitamin supplement: vitamin status, tablet burden and adherence	Katie Marsden	Received

P-177	A review of vitamin levels in children with cystic fibrosis following the introduction of a multi-vitamin preparation	harriet gledhill	Received

P-180	Food access challenges and social needs for people with cystic fibrosis	Cristen Clemm	Received

P-181	Nutrition support at an adult cystic fibrosis centre	Mandisa Mitchell-Whyte	Received

P-182	Developing a model for self-care support of diet and the gut in the routine care of children with cystic fibrosis: a qualitative study	Laurie Cave	Received

P-183	The role of the nutritionist in care of adult patients with cystic fibrosis in Republic of North Macedonia	Sonja Panovska	Received

P-184	Going green: patient awareness of inhaler indication, usage and environmental impact	Kizzy Snow	Received

P-185	Health literacy in children with cystic fibrosis	Cherie Millar	Received

P-186	The use of Recombinant human DNase in a large adult cystic fibrosis centre: a quality improvement review	Alison Orr	Received

P-187	Measuring the effect of airway clearance in adults with cystic fibrosis a systematic review	Gemma Stanford	Received

P-188	Non-invasive ventilation use and management of adult cystic fibrosis patients at end of life	Lucy E Wadsworth	Received

P-189	Impact of triple CFTR modulation therapy on non-invasive ventilation use in adults with cystic fibrosis	Lucy E Wadsworth	Received

P-190	Adherence 50 to prescribed nebulisers in children with cystic fibrosis is associated with increased hospital admissions and lower FEV1 Z-Score	Kieren James Lock	Received

P-191	The use of technology and web-based exercise programmes to improve engagement and quality of exercise sessions delivered to paediatric inpatients during an admission	Louisa Wallbridge	Received

P-192	The introduction of a quality improvement focus group in a large UK adult cystic fibrosis centre	Jocelyn Choyce	Received

P-193	Audit of cough swab sampling techniques in children with cystic fibrosis	Zoe Johnstone	Received

P-194	Implementation of a cystic fibrosis-specific virtual pulmonary rehab program	Catherine Fordyce	Received

P-195	Using remote access musculoskeletal consultations within a cystic fibrosis specialist physiotherapy service: a pilot	Becky Dunphy	Received

P-196	Evaluation of the efficiency of Frequencer and Vest airways clearance devices in adult cystic fibrotic patients	Peter Borka	Received

P-197	Dysglycaemia and changes in aerobic function in cystic fibrosis	Owen Tomlinson	Received

P-198	Physical activity is associated with aerobic capacity and lung function in adults with cystic fibrosis	Maire Curran	Received

P-199	Assessing the effectiveness of a six-month partially supervised outpatient exercise programme for adults with cystic fibrosis: a service evaluation	Ann Banks	Received

P-200	Supporting exercise services in cystic fibrosis: five years of the UK CF & Exercise Network	Owen Tomlinson	Received

P-201	The effectiveness of exercise interventions to increase physical activity in cystic fibrosis: a systematic review	Maire Curran	Received

P-202	The evaluation of sinonasal and health symptoms in children with cystic fibrosis on Orkambi or Symkevi using the SNOT-22	Gemma Murray	Received

P-203	Fertile ground: pregnancies in a post-Kaftrio pandemic era	Aoife Lillis	Received

P-204	The what-ifs....considering the psychological impacts of CFTR modulators	Michele Puckey	Received

P-205	Patient-reported outcome measures in the current context of new generation modulator therapies in cystic fibrosis	Kate Hayes	Received

P-206	Patient feedback following the introduction of a dedicated Symkevi Initiation Clinic prior to starting modulator therapy	Lynette Haigh	Received

P-207	Depression and inflammation in people with cystic fibrosis: a pilot study	Fabiana Ciciriello	Received

P-208	Anxiety, depression and resilience during COVID-19 in Dutch patients with cystic fibrosis or primary ciliary dyskinesia and their caregivers	Marieke Verkleij	Received

P-209	Key priorities in mental health research: results of a community and provider survey across the US	Beth Smith	Received

P-210	COACH project - screening for psychological comorbidity in adolescents with cystic fibrosis	Svenja Temming	Received

P-211	Use of telemedicine for mental health screening during the COVID-19 pandemic	Heather Bruschwein	Received

P-212	Understanding (the experiences of) how mindfulness is used by people with cystic fibrosis: barriers and enablers	Sophia Kauser	Received

P-213	Can we attend anywhere? Evaluation of multi-disciplinary team (MDT) remote consultations	Lisa Morrison	Received

P-214	Virtual cystic fibrosis doctor: design, development, and user experience pilot study	David Morrissy	Received

P-215	Contrasting patient and paediatric cystic fibrosis team perception of telemedicine consultations	Ema Kavaliunaite	Received

P-217	Delivering quality improvement coaching in a virtual world: the use of digital technology to empower and engage CFDigiCare clinicians to undertake quality improvement activities nationally	Charlotte Carolan	Received

P-218	Detection of anxiety and depression through mental health screening questionnaires in cystic fibrosis patients and their families during the COVID-19 pandemic	Ana Morales Tirado	Received

P-219	Before and during the COVID-19 pandemic: a review of health of our paediatric cystic fibrosis patients	Lois Powell	Received

P-220	Experiences of virtual cystic fibrosis clinics during the Covid-19 pandemic at one UK adult cystic fibrosis centre	Louise Warnock	Received

P-221	Quality of life in adult and children with cystic fibrosis during the COVID-19 pandemic in Croatia	Tihana Odobasic Palkovic	Received

P-222	Supporting children with cystic fibrosis: building social networks through the pandemic	Ellie Mindel	Received

P-223	The role of psychologist in a cystic fibrosis centre during the COVID-19 pandemic experience of a Polish paediatric centre	Urszula Borawska-Kowalczyk	Received

P-224	Change in care during the COVID-19 pandemic: single-centre experience in a middle-income setting	Ilektra Toulia	Received

P-225	Parents feedback on virtual paediatric cystic fibrosis clinics during Covid-19 pandemic	Rachel Evans	Received

P-226	A survey of family experience of cystic fibrosis care during the COVID-19 pandemic	Jill Watkinson	Received

P-227	Cystic fibrosis social workers experience of working during COVID-19	Fiona Dowdall	Received

P-228	Concerns for people with cystic fibrosis when travelling pre-COVID-19	Cherie Millar	Received

P-229	Children and young people with cystic fibrosis enhanced multi-disciplinary pathways to address their educational needs during the evolving COVID-19 pandemic	Chandran Suja	Received

P-230	A review of paediatric cystic fibrosis care during the COVID-19 pandemic	Lois Powell	Received

P-231	Patient experience of accessing a virtual cystic fibrosis service during the 2020 SARS-CoV-2 pandemic in Blackpool, North West of England	Tarek Saba	Received

P-232	The impact of COVID-19 on the relationships between parents of young people diagnosed with cystic fibrosis and the cystic fibrosis multidisciplinary team	Steve Jones	Received

P-233	Treatment outcome preferences among people with cystic fibrosis: a discrete choice experiment	Rory Cameron	Received

P-234	CFHealthHub a digital learning health system supporting virtual clinics and self-care across 60 of UK adult CF centres: a survey to understand benefits amongst the national CFDigiCare community	Josie Cunningham	Received

P-235	Using a 1,500-patient learning health system (LHS) to support virtual clinics and medicines optimisation: a UK seven-centre Patient and Public Involvement (PPI) project to understand user experience	Sophie Dawson	Received

P-236	Quantifying the under-served or hard to reach but reachable people with cystic fibrosis (CF) in two UK adult CF centres	Sophie Dawson	Received

P-237	The role of beliefs in predicting adherence to nebulised medications in adolescents with cystic fibrosis	Bronwyn Stirzaker	Received

P-238	EMBRACEing Medicines Optimisation: working collaboratively to identify barriers and share solutions in the medication pathway across 12 sites within the CFHealthHub	Charlotte Carolan	Received

P-239	Pulmonary medication adherence among children and adults with cystic fibrosis	Elpis Hatziagorou	Received

P-240	Improving the accuracy of nebulizer prescriptions (and update where necessary) during the medication reconciliation process on CFHealthHub (within 24-hours)	Rianna White	Received

P-241	Middle-aged cystic fibrosis patients experiences of living with cystic fibrosis: a qualitative study	Lena Backstrm Eriksson	Received

P-242	Ageing with cystic fibrosis: how do older adults with cystic fibrosis adapt to change?	Steven Stirk	Received

P-243	The psychological impact of the late diagnosis of atypical cystic fibrosis patients	Guergana Petrova	Received

P-244	Moving from paediatric to adult care: resources to support transition	Jacqueline Ali	Received

P-246	Transition in cystic fibrosis: international trends	Daniel Office	Received

P-247	Improved quality of care increases lung function and growth parameters in children with cystic fibrosis	Fabien Beaufils	Received

P-248	Patient Science: a new citizen science approach for health and medical research involving people affected by cystic fibrosis	Johanna Gardecki	Received

P-249	Mens health in cystic fibrosis in the modern era: a qualitative study	Traci Kazmerski	Received

P-250	Correlation between care allowance levels and antibiotic treatment at the Stockholm Cystic Fibrosis Centre	Eleonora Falk	Received

P-251	The experience of adults with cystic fibrosis engaging in a complex health management regime: a meta-ethnography	Steven Stirk	Received

P-252	Evaluation of a dashboard-style 1-page coloured CF annual review summary as a novel feedback method to improve communication with families and aid MDT working.	Alison Coates	Received

P-253	Share the Sunshine to Improve Staff Wellbeing	Sarah Simmons	Received

P-254	Development of a primary palliative care model that includes a novel approach to address the needs of caregivers of adults with cystic fibrosis - improving life with cystic fibrosis: a primary palliative care partnership	Anna Georgiopoulos	Received

P-255	Parenthood experience of cystic fibrosis patients and their spouses - An explorative study	Anne Jacob	Received

P-256	Waiting for double lung transplantation: psychological impact (review)	Trudy Havermans	Received

P-257	Directions of psychological and pedagogical support of children with cystic fibrosis	Sviridova Tatiana	Received

P-258	Integrating a diabetes service within the Adult Cystic Fibrosis Service at Blackpool Victoria Hospital, UK	Julie Knowles	Received

About us

FAQs

Search and consult posters online
in an exclusive section
for each poster

ACTIVE FROM 09/06/2021 TO 07/06/2024

Poster
Gallery

Upload
Poster

Featured Poster

Vote poster

Poster Discussion
Forum



		Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.

About us

Terms and Conditions

Special Access

Commercial Web Access